Metabolic syndrome and psoriasis

DOI: https://doi.org/10.29296/25877305-2018-07-05
Download full text PDF
Issue: 
7
Year: 
2018

E. Dvoryankova(1), MD; Professor I. Korsunskaya(1), MD; I. Sorkina(2) 1-Center for Theoretical Problems of Physicochemical Pharmacology, Moscow 2-AO «K+31 Clinic», Moscow

The paper describes current views on the pathogenesis of metabolic syndrome and its correlation with skin abnormality, such as psoriasis. It indicates the relationship between insulin resistance and the severity of the psoriatic process. There are data on the management of patients with metabolic syndrome and psoriasis: the design of a follow-up and the recommendations for lifestyle and combination therapy.
Keywords: 
dermatology
psoriasis
metabolic syndrome
comorbidity of psoriasis

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Oda E. Metabolic syndrome: its history, mechanisms, and limitations // Acta Diabetol. – 2012; 49 (2): 89–95.
  2. Alberti K., Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation // Diabet Med. – 1998; 15 (7): 539–53.
  3. Huang P. A comprehensive definition for metabolic syndrome // Dis. Model Mech. – 2009; 2 (5–6): 231–7.
  4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) // JAMA. – 2001; 285 (19): 2486–97.
  5. Leroith D. Pathophysiology of the metabolic syndrome: implications for the cardiometabolic risks associated with type 2 diabetes // Am. J. Med. Sci. – 2012; 343 (1): 13–6.
  6. van Waateringe R., Slagter S., van Beek A. et al. Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components // Diabetol. Metab. Syndr. – 2017; 9: 42.
  7. Zindanci I., Albayrak O., Kavala M. et al. Prevalence of metabolic syndrome in patients with psoriasis // Scientific World J. – 2012; 2012: 312463.
  8. Borska L., Kremlacek J., Andrys C. et al. Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis // Int. J. Mol. Sci. – 2017; 18 (11): 1549–57.
  9. Radtke M., Mrowietz U., Feuerhahn J. et al. Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis // J. Dtsch. Dermatol. Ges. – 2015; 13 (7): 674–90.
  10. Mikrjukov A.V., Perlamutrov Ju.N. Terapija bol'nyh vul'garnym psoriazom s izbytochnoj massoj tela i ozhireniem // Vestnik poslediplomnogo meditsinskogo obrazovanija. – 2013; 2: 27–30.